Aerie Pharmaceuticals
Innovative ophthalmic therapies for glaucoma, dry eye, and retinal diseases. Learn more
Launch date
Employees
Market cap
CAD1.0b
Enterprise valuation
CAD1.3b (Public information from Nov 2022)
Share price
$15.25 AERI
Durham North Carolina (HQ)
Authorizing premium user...